Skip to content
About
Our Team
Scientific Approach
Our Engineering
Our Platform
Publications
Pipeline & Programs
Our Pipeline
GNTI-122
Careers
News
Contact
Toggle navigation
About
Our Team
Scientific Approach
Our Engineering
Our Platform
Publications
Pipeline & Programs
Our Pipeline
GNTI-122
Careers
News
Contact
Cook et al. (2023)
Molecular Therapy Journal
31
. 8
Post navigation
Previous:
Generation of Islet-specific Engineered Regulatory T Cells (EngTregs) for Immune Tolerance Induction in Type 1 Diabetes Using a Novel Dual-editing Strategy
Next:
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes
Toggle navigation